Evaluating masking in a randomized, double-masked clinical trial in children with myopia

Optometry and Vision Science

Volumn 83, Issue 1, 2006, Pages 46-52

  Dong, Li Ming ^a   Hyman, Leslie ^a   Manny, Ruth E ^b   Thomas, Jennifer ^a   Dias, Lynette ^a   Mcleod, Jennifer ^b   Gwiazda, Jane ^c  

^a STONY BROOK UNIVERSITY   (United States)

^b UNIVERSITY OF HOUSTON   (United States)

^c NEW ENGLAND COLLEGE OF OPTOMETRY   (United States)

Author keywords

Clinical trial; Myopia; Progressive addition lens; Single vision lens; Success of masking

Indexed keywords

CONTACT LENSES; DATA REDUCTION; PATIENT TREATMENT; VISION;

CLINICAL TRIAL; MYOPIA; PROGRESSIVE ADDITION LENS; SUCCESS OF MASKING;

DISEASES;

ANALYSIS OF VARIANCE; ARTICLE; CHILD; CONTACT LENS; CONTROLLED STUDY; DATA ANALYSIS; ETHNOLOGY; FEMALE; FOLLOW UP; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MASKING; MYOPIA; OPTOMETRY; OUTCOME ASSESSMENT; PARENT; PRIORITY JOURNAL; QUESTIONNAIRE; SEX DIFFERENCE;

CHILD; DOUBLE-BLIND METHOD; EQUIPMENT DESIGN; EYEGLASSES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MYOPIA; OBSERVER VARIATION; PATIENT SELECTION; QUESTIONNAIRES; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 33644842939     PISSN: 10405488     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.opx.0000195564.38235.39     Document Type: Article

References (16)

1. Pocock SJ. Clinical Trials: A Practical Approach. New York: Wiley; 1983;90-99.
2. Schulz KF, Grimes DA. Blinding in randomised trials: hiding who got what. Lancet 2002;359:696-700.
3. Moher D, Schulz KF, Altman D. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA 2001;285:1987-91.
4. Altman DG, Schulz KF, Moher D, Egger M, Davidoff F, Elbourne D, Gotzsche PC, Lang T. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 2001;134:663-94.
5. Fergusson D, Glass KC, Waring D, Shapiro S. Turning a blind eye: the success of blinding reported in a random sample of randomised, placebo controlled trials. BMJ 2004;328:432. Epub 2004 Jan. 22.
6. Moscucci M, Byrne L, Weintraub M, Cox C. Blinding, unblinding, and the placebo effect: an analysis of patients' guesses of treatment assignment in a double-blind clinical trial. Clin Pharmacol Ther 1987;41:259-65.
7. Byington RP, Curb JD, Mattson ME. Assessment of double-blindness at the conclusion of the beta-Blocker Heart Attack Trial. JAMA 1985;253:1733-6.
8. Hughes JR, Krahn D. Blindness and the validity of the double-blind procedure. J Clin Psychopharmacol 1985;5:138-42.
9. Margraf J, Ehlers A, Roth WT, Clark DB, Sheikh J, Agras WS, Taylor CB. How 'blind' are double-blind studies? J Consult Clin Psychol 1991;59:184-7.
10. Noseworthy JH, Ebers GC, Vandervoort MK, Farquhar RE, Yetisir E, Roberts R. The impact of blinding on the results of a randomized, placebo-controlled multiple sclerosis clinical trial. 1994 [classical article]. Neurology 2001;57:S31-5.
11. Rabkin JG, Markowitz JS, Stewart J, McGrath P, Harrison W, Quitkin FM, Klein DF. How blind is blind? Assessment of patient and doctor medication guesses in a placebo-controlled trial of imipramine and phenelzine. Psychiatry Res 1986;19:75-86.
12. Hyman L, Gwiazda J, Marsh-Tootle WL, Norton TT, Hussein M. The Correction of Myopia Evaluation Trial (COMET): design and general baseline characteristics. Control Clin Trials 2001;22:573-92.
13. Gwiazda J, Hyman L, Hussein M, Everett D, Norton TT, Kurtz D, Leske MC, Manny R, Marsh-Tootle W, Scheiman M. A randomized clinical trial of progressive addition lenses versus single vision lenses on the progression of myopia in children. Invest Ophthalmol Vis Sci 2003;44:1492-500.
14. Hyman L, Gwiazda J, Hussein M, Norton TT, Wang Y, Marsh-Tootle W, Everett D; the COMET Group. Relationship of baseline age, gender and ethnicity with 3-year myopia progression and axial elongation in the Correction of Myopia Evaluation Trial (COMET). Arch Ophthalmol 2005;123: in press.
15. rd ed. Hoboken, NJ: Wiley; 1981.
16. Sharpe L, Ryan B, Allard S, Sensky T. Testing for the integrity of blinding in clinical trials: how valid are forced choice paradigms? Psychother Psychosom 2003;72:128-31.